Roger Dansey
AuthID: R-00F-TXV
1
TITLE: Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors Full Text
AUTHORS: David Henry; Saroj Vadhan Raj; Vera Hirsh; Roger von Moos; Vania Hungria; Luis Costa; Penella J Woll; Giorgio Scagliotti; Geoffrey Smith; Amy Feng; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2014, SOURCE: SUPPORTIVE CARE IN CANCER, VOLUME: 22, ISSUE: 3
AUTHORS: David Henry; Saroj Vadhan Raj; Vera Hirsh; Roger von Moos; Vania Hungria; Luis Costa; Penella J Woll; Giorgio Scagliotti; Geoffrey Smith; Amy Feng; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2014, SOURCE: SUPPORTIVE CARE IN CANCER, VOLUME: 22, ISSUE: 3
2
TITLE: Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
AUTHORS: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2011, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, ISSUE: 9
AUTHORS: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2011, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, ISSUE: 9
INDEXED IN: 
WOS 
CrossRef
WOS CrossRef